Boston Scientific's total assets for Q4 2025 were $43.67B, an increase of 2.26% from the previous quarter. BSX total liabilities were $19.20B for the fiscal quarter, a 0.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.